Inventor

BENJAMIN WHALLEY

Inventor
GB

Overview

18→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
C07CAcyclic or carbocyclic compounds11%
B01DSeparation5%
C07DHeterocyclic compounds2%
PatentTitleYear
12,403,136Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof202512,396,963Cannabidiol-type cannabinoid compound202512,383,512Cannabidiol-type cannabinoid compound202512,364,670Cannabidiol-type cannabinoid compound202512,357,586Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy202512,350,253Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease202512,263,139Use of cannabidiol in the treatment of tuberous sclerosis complex202512,121,499Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)202411,944,600Use of cannabinoids in the treatment of a neurodegenerative disease or disorder202411,865,102Cannabidiol preparations and its uses202411,793,7707-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy202311,684,598Use of cannabinoids in the treatment of epilepsy202311,590,087Cannabidiol-type cannabinoid compound202311,419,829Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsy202211,318,109Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)202211,207,292Cannabidiol preparations and its uses202111,147,783Use of cannabinoids in the treatment of epilepsy202111,147,7767-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2024Patents assigned to GW RES LTD (9)· patent assignee history
2021–2025Based in GB· patent location history
2022–2024Patents assigned to GW PHARMA LTD (2)· patent assignee history
2022Patents assigned to OTSUKA PHARMA CO LTD (1)· patent assignee history
2025Patents assigned to JAZZ PHARMACEUTICALS RESEARCH UK LTD (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GW RES LTD92021–2024
JAZZ PHARMACEUTICALS RESEARCH UK LTD72025
GW PHARMA LTD22022–2024
OTSUKA PHARMA CO LTD12022
Locations
LocationPatentsSpan
GB182021–2025